Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,954 DKK | +0.85% | -0.08% | -9.35% |
Jun. 03 | Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study | MT |
Jun. 03 | Transcript : Genmab A/S - Special Call |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Highlights